Table 3 Correlations between BOMP and oPMN parameters stratified according to gender
BOMP | ||||||
---|---|---|---|---|---|---|
Total (n=268) | Males (n=150) | Females (n=118) | ||||
oPMN parameters | r | P-value* | r | P-value* | r | P-value* |
Counts | 0.163 | 0.008 | 0.215 | 0.008 | 0.009 | 0.922 |
Cell cycle analysis | ||||||
Non-apoptotic | −0.018 | 0.768 | 0.002 | 0.979 | −0.049 | 0.599 |
Early apoptosis | 0.007 | 0.909 | −0.027 | 0.743 | 0.067 | 0.470 |
Late apoptosis | 0.012 | 0.841 | 0.005 | 0.952 | 0.025 | 0.786 |
Cell activation | ||||||
CD11b | 0.117 | 0.056 | 0.110 | 0.181 | 0.149 | 0.107 |
CD63 | 0.003 | 0.963 | −0.012 | 0.886 | 0.043 | 0.641 |
CD66b | 0.015 | 0.811 | 0.047 | 0.567 | −0.007 | 0.943 |
Total ROS | ||||||
Unstimulated | 0.142 | 0.020 | 0.179 | 0.028 | −0.018 | 0.845 |
F. nucleatum | 0.131 | 0.032 | 0.142 | 0.082 | 0.075 | 0.420 |
Extracellular ROS | ||||||
Unstimulated | −0.065 | 0.288 | −0.097 | 0.236 | −0.009 | 0.922 |
F. nucleatum | 0.066 | 0.279 | 0.075 | 0.359 | 0.030 | 0.746 |